Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Marimed (MRMD) Leases (2019 - 2025)

Marimed has reported Leases over the past 7 years, most recently at $4.0 million for Q4 2025.

  • Quarterly Leases fell 1.2% to $4.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.0 million through Dec 2025, down 1.2% year-over-year, with the annual reading at $4.0 million for FY2025, 1.2% down from the prior year.
  • Leases was $4.0 million for Q4 2025 at Marimed, down from $8.0 million in the prior quarter.
  • Over five years, Leases peaked at $10.1 million in Q1 2023 and troughed at $53908.0 in Q3 2021.
  • The 5-year median for Leases is $3.8 million (2024), against an average of $4.4 million.
  • Year-over-year, Leases tumbled 98.76% in 2021 and then surged 1657.29% in 2023.
  • A 5-year view of Leases shows it stood at $5.1 million in 2021, then tumbled by 85.97% to $713000.0 in 2022, then skyrocketed by 362.13% to $3.3 million in 2023, then rose by 23.61% to $4.1 million in 2024, then fell by 1.2% to $4.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Leases are $4.0 million (Q4 2025), $8.0 million (Q3 2025), and $8.3 million (Q2 2025).